Article | Published:

Guiding intracortical brain tumour cells to an extracortical cytotoxic hydrogel using aligned polymeric nanofibres

Nature Materials volume 13, pages 308316 (2014) | Download Citation

Abstract

Glioblastoma multiforme is an aggressive, invasive brain tumour with a poor survival rate. Available treatments are ineffective and some tumours remain inoperable because of their size or location. The tumours are known to invade and migrate along white matter tracts and blood vessels. Here, we exploit this characteristic of glioblastoma multiforme by engineering aligned polycaprolactone (PCL)-based nanofibres for tumour cells to invade and, hence, guide cells away from the primary tumour site to an extracortical location. This extracortial sink is a cyclopamine drug-conjugated, collagen-based hydrogel. When aligned PCL-nanofibre films in a PCL/polyurethane carrier conduit were inserted in the vicinity of an intracortical human U87MG glioblastoma xenograft, a significant number of human glioblastoma cells migrated along the aligned nanofibre films and underwent apoptosis in the extracortical hydrogel. Tumour volume in the brain was significantly lower following insertion of aligned nanofibre implants compared with the application of smooth fibres or no implants.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , , & Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973–1991. J. Neurosurg. 88, 1–10 (1998).

  2. 2.

    , & Emerging concepts in glioma biology: implications for clinical protocols and rational treatment strategies. Neurosurg. Focus 19, E3 (2005).

  3. 3.

    et al. Recurrence pattern in glioblastoma multiforme patients treated with anti-angiogenic chemotherapy. J. Cancer Res. Clin. Oncol. 135, 1239–1244 (2009).

  4. 4.

    et al. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery. Neurosurgery 35, 378–388 (1994).

  5. 5.

    et al. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 25, 2524–2533 (2007).

  6. 6.

    , , , & Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int. J. Biochem. Cell Biol. 36, 1046–1069 (2004).

  7. 7.

    & Glioblastoma cells do not intravasate into blood vessels. Neurosurgery 36, 124–132 (1995).

  8. 8.

    et al. Induction of medulloblastomas in mice by sonic hedgehog, independent of Gli1. Cancer Res. 62, 6385–6389 (2002).

  9. 9.

    et al. Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas. Cancer Res. 68, 2241–2249 (2008).

  10. 10.

    et al. The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers. J. Neurosurg. 76, 640–647 (1992).

  11. 11.

    Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas. Cancer Res. 37, 1450–1454 (1977).

  12. 12.

    , , & The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis. J. Neurosci. Methods 115, 97–105 (2002).

  13. 13.

    , , , & Actin-based biomechanical features of suspended normal and cancer cells. J. Biosci. Bioeng. 116, 380–385 (2013).

  14. 14.

    , & Directed nerve outgrowth is enhanced by engineered glial substrates. Exp. Neurol. 184, 141–152 (2003).

  15. 15.

    et al. Sonic hedgehog induces capillary morphogenesis by endothelial cells through phosphoinositide 3-kinase. J. Biol. Chem. 278, 8244–8249 (2003).

  16. 16.

    , , , & Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am. J. Pathol. 163, 1801–1815 (2003).

  17. 17.

    , , , & In vivo assay for tumor cell invasion. Methods Mol. Biol. 571, 227–238 (2009).

  18. 18.

    , , , & The in vivo invasion assay: preparation and handling of collection needles. Cold Spring Harbor Protocols 10, 1232–1234 (2011).

  19. 19.

    , , & The role of aligned polymer fiber-based constructs in the bridging of long peripheral nerve gaps. Biomaterials 29, 3117–3127 (2008).

  20. 20.

    et al. The upregulation of specific interleukin (IL) receptor antagonists and paradoxical enhancement of neuronal apoptosis due to electrode induced strain and brain micromotion. Biomaterials 33, 5983–5996 (2012).

Download references

Acknowledgements

We would like to thank J. Leisen for his technical expertise with the MR scanner and J. Lyon and S. Nayebosadri for their assistance with the animal surgeries and immunohistochemistry. We would also like to acknowledge funding support for this project from National Institutes of Health EUREKA R01 CA153229 (NCI) (R.V.B.), the Georgia Research Alliance (R.V.B.), and Ian’s Friends Foundation (R.V.B.)

Author information

Author notes

    • Anjana Jain

    Present address: Department of Biomedical Engineering, Worcester Polytechnic Institute, 100 Institute Road, Worcester, Massachusetts 01609 USA,

Affiliations

  1. Neurological Biomaterials and Cancer Therapeutics Laboratory, Wallace H. Coulter Department of Biomedical Engineering Georgia Institute of Technology/Emory University School of Medicine, 313 Ferst Drive, Atlanta Georgia 30332 USA

    • Anjana Jain
    • , Martha Betancur
    • , Gaurangkumar D. Patel
    • , Chandra M. Valmikinathan
    • , Vivek J. Mukhatyar
    • , Ajit Vakharia
    • , S. Balakrishna Pai
    •  & Ravi V. Bellamkonda
  2. Department of Neurosurgery Children’s Health Care of Atlanta Georgia 30342 USA

    • Barunashish Brahma
  3. Department of Pediatrics, Aflac Cancer And Blood Disorders Center Emory University School of Medicine Atlanta, Georgia 30322 USA

    • Tobey J. MacDonald

Authors

  1. Search for Anjana Jain in:

  2. Search for Martha Betancur in:

  3. Search for Gaurangkumar D. Patel in:

  4. Search for Chandra M. Valmikinathan in:

  5. Search for Vivek J. Mukhatyar in:

  6. Search for Ajit Vakharia in:

  7. Search for S. Balakrishna Pai in:

  8. Search for Barunashish Brahma in:

  9. Search for Tobey J. MacDonald in:

  10. Search for Ravi V. Bellamkonda in:

Contributions

R.V.B. conceived the tumour ‘exvasion’ strategy using nanofibre films towards an apoptosis-inducing hydrogel and was responsible for the overall study design. A.J. implemented the above strategy by means of the design of a nanofibre tumour guide and a hydrogel sink, and also performed the surgeries, designed the experiments and analysed the results. M.B. oversaw the smooth film control studies, as well as quantified the Ki-67+ staining and tumour volume. G.D.P. fabricated the polymer conduits and nanofibre films. C.M.V. designed and performed the collagen and cyclopamine collagen two-well depot Live/Dead experiments, based on a cyclopamine strategy suggested by T.J.M. V.J.M. assisted with animal surgeries and tissue sectioning. A.V. performed haematoxylin and eosin staining and helped with histological assessment. S.B.P. stably transfected the U87MG cells to express eGFP. B.B helped with surgical strategy.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Ravi V. Bellamkonda.

Supplementary information

PDF files

  1. 1.

    Supplementary Information

    Supplementary Information

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nmat3878

Further reading